Cboe Global Markets achieved a record $532 million in revenue for Q3 2024, marking an 11% increase year-over-year. The company navigates market pressures while investing in growth and innovation.
Boston Scientific’s Q3 2023 earnings report highlights significant growth in cardiology, with year-to-date U.S. growth at 27%, driven by successful product launches and innovation.
LyondellBasell Industries reported mixed financial results for Q3 2024, with a net income drop but significant progress in sustainability, including new recycling initiatives and strong cash flow.
